ArticleCureus2026
Paralysis to Analysis: Unmasking Thyrotoxic Periodic Paralysis in a Middle-Aged Male Patient With Undiagnosed Graves Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism characterized by sudden-onset muscle weakness and hypokalemia due to intracellular potassium shifts. It most commonly affects young Asian men and is rarely seen in older adults or non-Asian populations. We present the case of a 52-year-old Hispanic male patient who experienced episodic bilateral limb weakness and falls over several months, ultimately diagnosed as TPP secondary to previously undiagnosed Graves' disease. Despite normal neurologic imaging and no overt hyperthyroid symptoms, thyroid function testing revealed severe thyrotoxicosis. Treatment with potassium replacement, methimazole, and propranolol led to the resolution of symptoms. This case highlights the importance of maintaining a high index of suspicion for TPP in patients with recurrent weakness, even when demographic and clinical features are atypical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.